Insulin inhalation - Novo Nordisk
Alternative Names: AERx iDMS; NN 1998Latest Information Update: 21 Jan 2022
Price :
$50 *
At a glance
- Originator Aradigm Corporation
- Developer Novo Nordisk
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus; Type 2 diabetes mellitus